From No More Tears to no more superbug fears Posted on October 21, 2024 by recce_com From No More Tears to no more superbug fears
Here’s why you’ll see more ASX biotechs focus on Asia in the years ahead! Posted on October 16, 2024 by recce_com Here’s why you’ll see more ASX biotechs focus on Asia in the years ahead!
Recce’s Phase 2 trial for skin infections hits midway recruitment milestone Posted on October 9, 2024 by recce_com Recce’s Phase 2 trial for skin infections hits midway recruitment milestone
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Posted on October 2, 2024 by recce_com Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
Recce Pharmaceuticals Advances Antibiotic Development to Combat Antimicrobial Resistance Posted on September 9, 2024September 25, 2024 by recce_com Recce Pharmaceuticals Advances Antibiotic Development to Combat Antimicrobial Resistance
Recce’s reconnaissance against superbug – infiltrate, eliminate, escape undetected Posted on September 9, 2024September 25, 2024 by recce_com Recce’s reconnaissance against superbug – infiltrate, eliminate, escape undetected
Recce Pharmaceuticals Delivers the Opening Address at World Antimicrobial Resistance Congress 2024 Posted on September 6, 2024September 25, 2024 by recce_com Recce Pharmaceuticals Delivers the Opening Address at World Antimicrobial Resistance Congress 2024
Recce Pharmaceuticals – Executive Interview Posted on August 7, 2024September 25, 2024 by recce_com Recce Pharmaceuticals – Executive Interview
Recce Pharmaceuticals more than doubles SPP target with A$4.4 million taking raise proceeds to A$12.4 million Posted on August 5, 2024September 25, 2024 by recce_com Recce Pharmaceuticals more than doubles SPP target with A$4.4 million taking raise proceeds to A$12.4 million